| UniProt ID | GEMI_HUMAN | |
|---|---|---|
| UniProt AC | O75496 | |
| Protein Name | Geminin | |
| Gene Name | GMNN | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 209 | |
| Subcellular Localization | Cytoplasm. Nucleus. Mainly cytoplasmic but can be relocalized to the nucleus. | |
| Protein Description | Inhibits DNA replication by preventing the incorporation of MCM complex into pre-replication complex (pre-RC). It is degraded during the mitotic phase of the cell cycle. Its destruction at the metaphase-anaphase transition permits replication in the succeeding cell cycle.; Inhibits the transcriptional activity of a subset of Hox proteins, enrolling them in cell proliferative control.. | |
| Protein Sequence | MNPSMKQKQEEIKENIKNSSVPRRTLKMIQPSASGSLVGRENELSAGLSKRKHRNDHLTSTTSSPGVIVPESSENKNLGGVTQESFDLMIKENPSSQYWKEVAEKRRKALYEALKENEKLHKEIEQKDNEIARLKKENKELAEVAEHVQYMAELIERLNGEPLDNFESLDNQEFDSEEETVEDSLVEDSEIGTCAEGTVSSSTDAKPCI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Phosphorylation | ----MNPSMKQKQEE ----CCHHHHHHHHH | 33.34 | 28122231 | |
| 6 | Ubiquitination | --MNPSMKQKQEEIK --CCHHHHHHHHHHH | 59.69 | - | |
| 6 | Acetylation | --MNPSMKQKQEEIK --CCHHHHHHHHHHH | 59.69 | 25953088 | |
| 17 | Ubiquitination | EEIKENIKNSSVPRR HHHHHHHHCCCCCHH | 63.46 | - | |
| 25 | Phosphorylation | NSSVPRRTLKMIQPS CCCCCHHHHHHHCCC | 31.82 | - | |
| 27 | Ubiquitination | SVPRRTLKMIQPSAS CCCHHHHHHHCCCCC | 33.09 | 19608861 | |
| 27 | Acetylation | SVPRRTLKMIQPSAS CCCHHHHHHHCCCCC | 33.09 | 19608861 | |
| 28 | Sulfoxidation | VPRRTLKMIQPSASG CCHHHHHHHCCCCCC | 3.75 | 21406390 | |
| 32 | O-linked_Glycosylation | TLKMIQPSASGSLVG HHHHHCCCCCCCCCC | 20.77 | OGP | |
| 32 | Phosphorylation | TLKMIQPSASGSLVG HHHHHCCCCCCCCCC | 20.77 | 23403867 | |
| 34 | Phosphorylation | KMIQPSASGSLVGRE HHHCCCCCCCCCCCH | 33.00 | 23403867 | |
| 36 | O-linked_Glycosylation | IQPSASGSLVGRENE HCCCCCCCCCCCHHH | 19.86 | 30379171 | |
| 36 | Phosphorylation | IQPSASGSLVGRENE HCCCCCCCCCCCHHH | 19.86 | 23403867 | |
| 45 | Phosphorylation | VGRENELSAGLSKRK CCCHHHHCHHHCCCC | 17.70 | 23403867 | |
| 49 | Phosphorylation | NELSAGLSKRKHRND HHHCHHHCCCCCCCC | 29.51 | 23401153 | |
| 50 | Acetylation | ELSAGLSKRKHRNDH HHCHHHCCCCCCCCC | 71.19 | 25953088 | |
| 50 | Ubiquitination | ELSAGLSKRKHRNDH HHCHHHCCCCCCCCC | 71.19 | 21906983 | |
| 52 | Ubiquitination | SAGLSKRKHRNDHLT CHHHCCCCCCCCCCC | 51.13 | - | |
| 59 | Phosphorylation | KHRNDHLTSTTSSPG CCCCCCCCCCCCCCC | 22.17 | 22167270 | |
| 60 | Phosphorylation | HRNDHLTSTTSSPGV CCCCCCCCCCCCCCE | 35.73 | 22167270 | |
| 61 | Phosphorylation | RNDHLTSTTSSPGVI CCCCCCCCCCCCCEE | 26.01 | 22167270 | |
| 62 | Phosphorylation | NDHLTSTTSSPGVIV CCCCCCCCCCCCEEC | 27.29 | 22167270 | |
| 63 | Phosphorylation | DHLTSTTSSPGVIVP CCCCCCCCCCCEECC | 34.32 | 22167270 | |
| 64 | Phosphorylation | HLTSTTSSPGVIVPE CCCCCCCCCCEECCC | 24.47 | 22167270 | |
| 72 | Phosphorylation | PGVIVPESSENKNLG CCEECCCCCCCCCCC | 36.56 | 20068231 | |
| 73 | Phosphorylation | GVIVPESSENKNLGG CEECCCCCCCCCCCC | 43.45 | 29978859 | |
| 76 | Ubiquitination | VPESSENKNLGGVTQ CCCCCCCCCCCCCCH | 49.88 | - | |
| 82 | Phosphorylation | NKNLGGVTQESFDLM CCCCCCCCHHHHHHH | 29.87 | 23186163 | |
| 85 | Phosphorylation | LGGVTQESFDLMIKE CCCCCHHHHHHHCCC | 17.78 | 22912867 | |
| 91 | Ubiquitination | ESFDLMIKENPSSQY HHHHHHCCCCCCHHH | 37.16 | - | |
| 95 | Phosphorylation | LMIKENPSSQYWKEV HHCCCCCCHHHHHHH | 41.47 | - | |
| 96 | Phosphorylation | MIKENPSSQYWKEVA HCCCCCCHHHHHHHH | 28.66 | - | |
| 98 | Phosphorylation | KENPSSQYWKEVAEK CCCCCHHHHHHHHHH | 22.01 | - | |
| 100 | Ubiquitination | NPSSQYWKEVAEKRR CCCHHHHHHHHHHHH | 37.06 | - | |
| 105 | Acetylation | YWKEVAEKRRKALYE HHHHHHHHHHHHHHH | 48.00 | 20167786 | |
| 108 | Ubiquitination | EVAEKRRKALYEALK HHHHHHHHHHHHHHH | 46.94 | - | |
| 111 | Phosphorylation | EKRRKALYEALKENE HHHHHHHHHHHHHHH | 12.19 | 27642862 | |
| 115 | Ubiquitination | KALYEALKENEKLHK HHHHHHHHHHHHHHH | 66.59 | - | |
| 122 | Ubiquitination | KENEKLHKEIEQKDN HHHHHHHHHHHHHHH | 71.47 | - | |
| 127 | Ubiquitination | LHKEIEQKDNEIARL HHHHHHHHHHHHHHH | 50.13 | - | |
| 139 | Ubiquitination | ARLKKENKELAEVAE HHHHHHHHHHHHHHH | 56.02 | 22053931 | |
| 150 | Phosphorylation | EVAEHVQYMAELIER HHHHHHHHHHHHHHH | 9.37 | - | |
| 184 | Phosphorylation | EEETVEDSLVEDSEI CCCCHHHHCCCCCCC | 22.32 | 14702039 | |
| 200 | Phosphorylation | TCAEGTVSSSTDAKP CCCCCCCCCCCCCCC | 20.57 | 17261582 | |
| 201 | Phosphorylation | CAEGTVSSSTDAKPC CCCCCCCCCCCCCCC | 32.68 | 17261582 | |
| 202 | Phosphorylation | AEGTVSSSTDAKPCI CCCCCCCCCCCCCCC | 23.85 | 17261582 | |
| 203 | Phosphorylation | EGTVSSSTDAKPCI- CCCCCCCCCCCCCC- | 41.76 | 17261582 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 25 | T | Phosphorylation | Kinase | AURKA | O14965 | GPS |
| 150 | Y | Phosphorylation | Kinase | ABL | P00519 | PSP |
| 184 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
| 184 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
| - | K | Ubiquitination | E3 ubiquitin ligase | FZR1 | Q9UM11 | PMID:21700221 |
| - | K | Ubiquitination | E3 ubiquitin ligase | ANAPC11 | Q9NYG5 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BMI1 | P35226 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | RNF2 | Q99496 | PMID:20697353 |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 184 | S | Phosphorylation |
| 22615398 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GEMI_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-27, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63 AND SER-64, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND MASSSPECTROMETRY. | |